研究發展處

Neuroscience

1. Migraine 100%
2. Headache 65%
3. Functional Magnetic Resonance Imaging 64%
4. Functional Connectivity 62%
5. Alzheimer's Disease 62%
6. Cognitive Disorders 37%
7. Electroencephalogram 34%
8. Major Depressive Disorder 34%
9. Magnetic Resonance Imaging 33%
10. Magnetic Resonance Imaging 33%
11. Gray Matter Volume 32%
12. Behavior (Neuroscience) 32%
13. Mild Cognitive Impairment 32%
14. Cognitive Function 31%
15. Cerebrovascular Accident 30%
16. Parkinson's Disease 28%
17. Hippocampus 28%
18. In Vivo 25%
19. Brain Network 23%
20. Amygdala 22%
21. Diffusion Tensor Imaging 20%
22. Heart Rate Variability 20%
23. Thalamus 19%
24. Gray Matter 19%
25. Blood Plasma 18%
26. Striatum 18%
27. Cerebellum 17%
28. Default Mode Network 17%
29. Receptor 17%
30. Obstructive Sleep Apnea 16%
31. Comorbidity 15%
32. Gyri 14%
33. Nociception 14%
34. Cluster Headache 14%
35. Antidepressant 13%
36. Pervasive Developmental Disorder 13%
37. Mental Disorder 13%
38. Glutamic Acid 13%
39. Electrotherapy 12%
40. Voxel-Based Morphometry 12%
41. Fractional Anisotropy 12%
42. Brain Ischemia 12%
43. Tractography 12%
44. Sleep Quality 12%
45. Longitudinal Study 12%
46. Depressive Disorder 12%
47. Magnetoencephalography 11%
48. Attention Deficit Hyperactivity Disorder 11%
49. Treatment-Resistant Depression 11%
50. Evoked Potential 11%
51. Frontal Lobe 11%
52. Fluorine-18 11%
53. Gamma-Aminobutyric Acid 11%
54. Neural Network 11%
55. Prefrontal Cortex 11%
56. Ketamine 11%
57. Neurodegenerative Disorder 11%
58. Orbitofrontal Cortex 11%
59. Brain-Derived Neurotrophic Factor 11%
60. Dopaminergic 10%
61. Brain-Computer Interface 10%
62. Programmed Cell Death 10%
63. Fibromyalgia 10%
64. Putamen 10%
65. Amyloid Protein 10%
66. Metabolic Pathway 10%
67. Positron Emission Tomography 10%
68. Cerebral Cortex 10%
69. Subjective Cognitive Decline 10%
70. Cerebrovascular Disease 10%
71. Brain Age 10%
72. Brain Areas 9%
73. Motor Cortex 9%
74. Temporal Lobe 9%
75. Oxidative Stress 9%
76. Cingulate Cortex 9%
77. Posterior Cingulate 9%
78. In Vitro 9%
79. Transcranial Magnetic Stimulation 9%
80. Executive Function 9%
81. Brain Imaging 9%
82. Brain Disease 9%
83. Hypertension 8%
84. Medication Overuse 8%
85. Corpus Callosum 8%
86. Brain Development 8%
87. Neuronal Activity 8%
88. Gene Expression 8%
89. Resting-State Functional Connectivity 8%
90. Somatosensory Cortex 8%
91. Nervous System Disorder 8%
92. Stem Cell 8%
93. Auras 8%
94. Anterior Cingulate Cortex 8%
95. Epoxide Hydrolase 8%
96. Interneuron 8%
97. Bipolar Disorder 8%
98. Neural Stem Cell 8%
99. Anxiety Disorder 7%
100. Autism 7%

Keyphrases

1. Migraine 68%
2. Taiwan 56%
3. Alzheimer's Disease 51%
4. Functional Connectivity 41%
5. Chronic Migraine 36%
6. Functional Magnetic Resonance Imaging 34%
7. Electroencephalography 34%
8. Major Depressive Disorder 33%
9. Healthy Controls 31%
10. Schizophrenia 31%
11. Gray Matter Volume 31%
12. Headache 30%
13. Cognitive Function 28%
14. Taiwanese 28%
15. Cognitive Impairment 26%
16. Brain Regions 26%
17. Parkinson's Disease 24%
18. Reversible Cerebral Vasoconstriction Syndrome 24%
19. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 23%
20. Mild Cognitive Impairment 23%
21. Magnetoencephalography 22%
22. Older Adults 20%
23. Dementia 20%
24. Confidence Interval 18%
25. Brain-computer Interface 18%
26. Heart Rate Variability 18%
27. Hippocampus 18%
28. Diffusion Tensor Imaging 18%
29. Obstructive Sleep Apnea 17%
30. Magnetic Resonance Imaging 17%
31. Migraine Patients 17%
32. Striatum 17%
33. Cluster Headache 16%
34. National Cohort Study 16%
35. Default Mode Network 16%
36. Cognitive Decline 14%
37. Electroencephalogram 14%
38. Resting State 14%
39. Treatment-resistant Depression 13%
40. Cerebellum 13%
41. Subjective Cognitive Decline 12%
42. Neuroimaging 12%
43. Intracranial Hypotension 12%
44. Autism Spectrum Disorder 12%
45. Attention Deficit Hyperactivity Disorder 12%
46. Voxel-based Morphometry 12%
47. Amygdala 12%
48. Odds Ratio 12%
49. Aging 12%
50. White Matter 11%
51. Pathophysiology 11%
52. Brain Networks 11%
53. Comorbidity 11%
54. Fractional Anisotropy 11%
55. Human Brain 11%
56. Mini-Mental State Examination 11%
57. Ketamine 10%
58. Neurodegenerative Diseases 10%
59. Brain Activity 10%
60. Brain Connectivity 10%
61. Age-related 10%
62. Primary Dysmenorrhea 10%
63. Oxidative Stress 10%
64. Brain Structure 10%
65. Episodic Migraine 10%
66. International Headache Society 10%
67. Resting-state Functional Connectivity (rs-FC) 10%
68. Fibromyalgia 10%
69. Healthy Adults 10%
70. Positron Emission Tomography 9%
71. Brain Aging 9%
72. Motor Cortex 9%
73. CISD2 9%
74. Sleep Quality 9%
75. Neural Correlates 9%
76. Randomized Controlled Trial 9%
77. Striatal 9%
78. Menstrual Pain 9%
79. Protein Kinase 9%
80. Bipolar Disorder 9%
81. Proteomic Analysis 9%
82. Inflammation 9%
83. Hazard Ratio 8%
84. Apoptosis 8%
85. Anterior Cingulate Cortex 8%
86. Cortex 8%
87. Neuroinflammation 8%
88. Cortical Neurons 8%
89. Antidepressants 8%
90. Steady-state Visual Evoked Potential (SSVEP) 8%
91. White Matter Hyperintensities 8%
92. Medication Overuse Headache 8%
93. Single nucleotide Polymorphism 8%
94. Schizophrenic Patients 8%
95. Sex Differences 8%
96. Ischemic Stroke 8%
97. Hepatocellular Carcinoma 8%
98. Neural Stem Cells 8%
99. Rat Model 8%
100. Psychiatric Disorders 8%